IO Biotech’s off-the-shelf cancer vaccine shows promise in melanoma with key data ahead, but funding risk limits near-term ...

A new study of female Medicare beneficiaries reveals that vulvar lichen sclerosus affects 7 out of every 1,000 women aged 65 and older, significantly higher than rates seen in younger populations. The ...

Dana-Farber research uncovered the potential for underdiagnosis of this aggressive cancer and identified additional tests ...

Older women with vulvar lichen sclerosus are more likely to develop a common type of vulvar cancer if left untreated but are likely underdiagnosed, suggesting that more counseling and regular skin ...

Researchers developed a diagnostic test based on the LIMA1-alpha protein to distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone, without the need for ...

AI model calculates a protein-based stemness index to predict tumor aggressiveness and treatment resistance. Proteomic-based ...

Transoral minimally invasive head and neck surgery has revolutionized the treatment of human papillomavirus (HPV)–positive oropharyngeal squamous cell carcinoma (OPC). 1 In 2009 and again in 2019, the ...

As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...

Panelists discuss how a woman aged 55 years with T3N1M0 locally advanced squamous cell carcinoma represents a typical case ...

4 Medical College, Nankai University, Tianjin, China Background: Nimotuzumab has shown promising efficacy in esophageal squamous cell carcinoma (ESCC). However, the efficacy and safety of nimotuzumab ...